Relugolix
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11853 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 28 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | Smouldering systemic mastocytosis | KG + DL |
| 3 | systemic mastocytosis | KG + DL |
| 4 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 5 | multiple endocrine neoplasia | KG + DL |
| 6 | gastrin secretion abnormality | KG + DL |
| 7 | leprosy | KG + DL |
| 8 | hypertrichosis (disease) | KG + DL |
| 9 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 10 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 11 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 12 | isolated genetic hair shaft abnormality | KG + DL |
| 13 | Legionnaires’ disease | KG + DL |
| 14 | HIV infectious disease | KG + DL |
| 15 | multidrug-resistant tuberculosis | KG + DL |
| 16 | coronary artery disease | KG + DL |
| 17 | Plasmodium falciparum malaria | KG + DL |
| 18 | anomalous left coronary artery from the pulmonary artery | KG + DL |
| 19 | abnormality of glucagon secretion | KG + DL |
| 20 | feline acquired immunodeficiency syndrome | KG + DL |
| 21 | simian immunodeficiency virus infection | KG + DL |
| 22 | oral candidiasis | KG + DL |
| 23 | migraine disorder | KG + DL |
| 24 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 25 | persistent Mullerian duct syndrome | KG + DL |
| 26 | commissural lip fistula | KG + DL |
| 27 | migraine with brainstem aura | KG + DL |
| 28 | myocardial ischemia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.